Security key
87184Q206
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)
CUSIP: 87184Q206
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 27,196,692
- Total 13F shares
- 10,562,398
- Share change
- +2,140,327
- Total reported value
- $37,917,223
- Put/Call ratio
- 0%
- Price per share
- $3.59
- Number of holders
- 51
- Value change
- +$7,584,586
- Number of buys
- 27
- Number of sells
- 14
Report period
Q4 2022
Institutions
51
Top holders
10
SYRS full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Syros Pharmaceuticals, Inc. SEC filings
Syros Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87184Q206
Recent filing periods:
Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Artal Group S.A. |
13F
|
Company |
5.4%
|
1,463,829
|
$9,427,000 | — | 30 Sep 2022 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
4%
|
1,082,404
|
$6,971,000 | — | 30 Sep 2022 | |
| Flagship Pioneering, LLC |
13F
|
Company |
3.7%
|
993,848
|
$6,400,000 | — | 30 Sep 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
3.3%
|
900,000
|
$5,796,000 | — | 30 Sep 2022 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
3.2%
|
868,403
|
$5,593,000 | — | 30 Sep 2022 | |
| Samsara BioCapital, LLC |
13F
|
Company |
3.1%
|
881,450
|
$5,677,000 | — | 30 Sep 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.7%
|
721,914
|
$4,649,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
487,533
|
$3,139,000 | — | 30 Sep 2022 | |
| CVI Holdings, LLC |
13F
|
Company |
1.6%
|
425,500
|
$2,740,000 | — | 30 Sep 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.98%
|
265,878
|
$1,712,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
0.93%
|
252,029
|
$1,623,000 | — | 30 Sep 2022 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.92%
|
251,270
|
$1,618,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.9%
|
245,233
|
$1,580,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
70,415
|
$453,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
69,634
|
$448,000 | — | 30 Sep 2022 | |
| LGT CAPITAL PARTNERS LTD. |
13F
|
Company |
0.2%
|
55,000
|
$354,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.16%
|
43,735
|
$282,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
33,132
|
$213,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.11%
|
29,524
|
$190,000 | — | 30 Sep 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.09%
|
24,565
|
$156,000 | — | 30 Sep 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.09%
|
23,886
|
$154,000 | — | 30 Sep 2022 | |
| PATHSTONE FAMILY OFFICE, LLC |
13F
|
Company |
0.08%
|
21,913
|
$141,120 | — | 30 Sep 2022 | |
| Clarius Group, LLC |
13F
|
Company |
0.07%
|
19,347
|
$125,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
15,206
|
$98,000 | — | 30 Sep 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.05%
|
12,800
|
$82,000 | — | 30 Sep 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.04%
|
11,835
|
$76,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
10,205
|
$66,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
9,661
|
$62,000 | — | 30 Sep 2022 | |
| EDMOND DE ROTHSCHILD HOLDING S.A. |
13F
|
Company |
0.02%
|
4,382
|
$28,000 | — | 30 Sep 2022 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
3,499
|
$23,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,652
|
$17,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,115
|
$7,000 | — | 30 Sep 2022 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
1,095
|
$7,000 | — | 30 Sep 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
1,066
|
$7,000 | — | 30 Sep 2022 | |
| Aquatic Capital Management LLC |
13F
|
Company |
0%
|
800
|
$5,000 | — | 30 Sep 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
750
|
$4,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
712
|
$5,000 | — | 30 Sep 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
650
|
$4,000 | — | 30 Sep 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
649
|
$4,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
502
|
$3,233 | — | 30 Sep 2022 | |
| Ten Capital Wealth Advisors, LLC |
13F
|
Company |
0%
|
219
|
$1,000 | — | 30 Sep 2022 | |
| CarsonAllaria Wealth Management, Ltd. |
13F
|
Company |
0%
|
162
|
$1,000 | — | 30 Sep 2022 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
129
|
$1,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
111
|
$1,000 | — | 30 Sep 2022 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
87
|
$1,000 | — | 30 Sep 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
50
|
$1,000 | — | 30 Sep 2022 | |
| Amir Nashat |
3/4/5
|
Director |
—
class O/S missing
|
17,500
|
— | — | 01 Jun 2022 | |
| Phillip A. Sharp |
3/4/5
|
Director |
—
class O/S missing
|
17,500
|
— | — | 01 Jun 2022 |
Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS) as of Q4 2022
As of 31 Dec 2022,
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,562,398 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, Artal Group S.A., Flagship Pioneering Inc., Avidity Partners Management LP, Samsara BioCapital, LLC, Ally Bridge Group (NY) LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, CVI Holdings, LLC, and Altium Capital Management LP.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
41
Q4 2022 holders
51
Holder diff
10
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.